$0.7331
-0.0565-7.16%
Last update: Oct 30, 2:20 PM
Milestone Pharmaceuticals Inc (MIST) Stock Price, Quote, News & History
MISTNASDAQ
Top Wall Street analysts updated ratings on SPHR, CVLG, MIST, MSGE,. Check out analyst ratings page for full details and stock recommendations.
You can purchase shares of Milestone Pharmaceuticals (NASDAQ:MIST) through any online brokerage.
Other companies in Milestone Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Milestone Pharmaceuticals has a consensus price target of $7.38.
The stock price for Milestone Pharmaceuticals (NASDAQ: MIST) is $0.7331 last updated October 30, 2026 at 2:20 PM EDT.
There are no upcoming dividends for Milestone Pharmaceuticals.
Milestone Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Milestone Pharmaceuticals.
Milestone Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the...
